Supply of NextSeq XLEAP-SBS Reagents

The contract specifies the supply of NextSeq XLEAP-SBS Reagents for use with NextSeq 1000 and 2000 sequencing systems to support high-throughput genomic sequencing operations. These reagents are essential for enabling accurate, scalable, and efficient DNA sequencing workflows, particularly in environments requiring rapid and large-scale data generation. The reagents must be compatible with the specified instrumentation and meet required performance and quality standards to ensure reliable results in high-demand applications such as clinical diagnostics, research, and defense-related biological initiatives. The contracting entity is the Defense Health Agency Hcd West under the Department of Defense, with performance located at Tripler Army Medical Center in Hawaii, ZIP code 96859. The solicitation, classified as a subcontract, was posted on May 4, 2026, with a response deadline of May 7, 2026, at 5:00 PM. The North American Industry Classification System code 325412 identifies the nature of the business involved in the manufacturing of in vitro diagnostics and reagents. The contract aims to support mission-critical biological data acquisition efforts within the military healthcare system, requiring timely and dependable delivery to maintain operational continuity.